426 related articles for article (PubMed ID: 25037231)
1. Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.
Naba A; Clauser KR; Whittaker CA; Carr SA; Tanabe KK; Hynes RO
BMC Cancer; 2014 Jul; 14():518. PubMed ID: 25037231
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer.
Voß H; Wurlitzer M; Smit DJ; Ewald F; Alawi M; Spohn M; Indenbirken D; Omidi M; David K; Juhl H; Simon R; Sauter G; Fischer L; Izbicki JR; Molloy MP; Nashan B; Schlüter H; Jücker M
Clin Exp Metastasis; 2020 Dec; 37(6):649-656. PubMed ID: 33099724
[TBL] [Abstract][Full Text] [Related]
3. Proteomics analysis of the matrisome from MC38 experimental mouse liver metastases.
Yuzhalin AE; Lim SY; Gordon-Weeks AN; Fischer R; Kessler BM; Yu D; Muschel RJ
Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G625-G639. PubMed ID: 31545917
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix proteins in metastases to the liver - Composition, function and potential applications.
Nyström H
Semin Cancer Biol; 2021 Jun; 71():134-142. PubMed ID: 32526353
[TBL] [Abstract][Full Text] [Related]
5. Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases.
Jailkhani N; Clauser KR; Mak HH; Rickelt S; Tian C; Whittaker CA; Tanabe KK; Purdy SR; Carr SA; Hynes RO
Cancer Res; 2023 Jun; 83(12):2052-2065. PubMed ID: 37098922
[TBL] [Abstract][Full Text] [Related]
6. Decellularized mice colons as models to study the contribution of the extracellular matrix to cell behavior and colon cancer progression.
Alabi BR; LaRanger R; Shay JW
Acta Biomater; 2019 Dec; 100():213-222. PubMed ID: 31562987
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival.
Gocheva V; Naba A; Bhutkar A; Guardia T; Miller KM; Li CM; Dayton TL; Sanchez-Rivera FJ; Kim-Kiselak C; Jailkhani N; Winslow MM; Del Rosario A; Hynes RO; Jacks T
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):E5625-E5634. PubMed ID: 28652369
[TBL] [Abstract][Full Text] [Related]
8. Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases.
Yang Q; Bavi P; Wang JY; Roehrl MH
J Proteomics; 2017 Sep; 168():53-65. PubMed ID: 28669815
[TBL] [Abstract][Full Text] [Related]
9. Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches.
Hebert JD; Myers SA; Naba A; Abbruzzese G; Lamar JM; Carr SA; Hynes RO
Cancer Res; 2020 Apr; 80(7):1475-1485. PubMed ID: 32019869
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters.
Naba A; Clauser KR; Lamar JM; Carr SA; Hynes RO
Elife; 2014 Mar; 3():e01308. PubMed ID: 24618895
[TBL] [Abstract][Full Text] [Related]
11. The cancer matrisome: From comprehensive characterization to biomarker discovery.
Socovich AM; Naba A
Semin Cell Dev Biol; 2019 May; 89():157-166. PubMed ID: 29964200
[TBL] [Abstract][Full Text] [Related]
12. Specific extracellular matrix remodeling signature of colon hepatic metastases.
Del Rio M; Mollevi C; Vezzio-Vie N; Bibeau F; Ychou M; Martineau P
PLoS One; 2013; 8(9):e74599. PubMed ID: 24023955
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Immune Microenvironment Between Colon and Liver Metastatic Tissue in Colon Cancer Patients with Liver Metastasis.
Zhou SN; Pan WT; Pan MX; Luo QY; Zhang L; Lin JZ; Zhao YJ; Yan XL; Yuan LP; Zhang YX; Yang DJ; Qiu MZ
Dig Dis Sci; 2021 Feb; 66(2):474-482. PubMed ID: 32193860
[TBL] [Abstract][Full Text] [Related]
14. [Different integrin-induced adhesion of highly liver metastatic and little metastatic colon carcinoma cells in an extracellular matrix].
Haier J; Nasralla M; Buhr HJ; Nicolson GL
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):307-13. PubMed ID: 14518266
[TBL] [Abstract][Full Text] [Related]
15. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.
Naba A; Clauser KR; Hoersch S; Liu H; Carr SA; Hynes RO
Mol Cell Proteomics; 2012 Apr; 11(4):M111.014647. PubMed ID: 22159717
[TBL] [Abstract][Full Text] [Related]
16. Tumor decellularization reveals proteomic and mechanical characteristics of the extracellular matrix of primary liver cancer.
van Tienderen GS; Conboy J; Muntz I; Willemse J; Tieleman J; Monfils K; Schurink IJ; Demmers JAA; Doukas M; Koenderink GH; van der Laan LJW; Verstegen MMA
Biomater Adv; 2023 Mar; 146():213289. PubMed ID: 36724550
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix proteins as diagnostic markers of breast carcinoma.
Giussani M; Landoni E; Merlino G; Turdo F; Veneroni S; Paolini B; Cappelletti V; Miceli R; Orlandi R; Triulzi T; Tagliabue E
J Cell Physiol; 2018 Aug; 233(8):6280-6290. PubMed ID: 29521413
[TBL] [Abstract][Full Text] [Related]
18. Recapitulating the human tumor microenvironment: Colon tumor-derived extracellular matrix promotes angiogenesis and tumor cell growth.
Romero-López M; Trinh AL; Sobrino A; Hatch MM; Keating MT; Fimbres C; Lewis DE; Gershon PD; Botvinick EL; Digman M; Lowengrub JS; Hughes CC
Biomaterials; 2017 Feb; 116():118-129. PubMed ID: 27914984
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Matrix Biomarkers in Colorectal Cancer.
Kim MS; Ha SE; Wu M; Zogg H; Ronkon CF; Lee MY; Ro S
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502094
[TBL] [Abstract][Full Text] [Related]
20. Ten Years of Extracellular Matrix Proteomics: Accomplishments, Challenges, and Future Perspectives.
Naba A
Mol Cell Proteomics; 2023 Apr; 22(4):100528. PubMed ID: 36918099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
